ArticleChemistry & biodiversity2026
Analysis of the Chemical Composition and Glycolipid Metabolism-Regulating Properties of Centella asiatica.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Centella Asiatica Alleviates Type 2 Diabetes-Related Hepatic Glycolipid Disorders via Regulating UPP1-Mediated Pyrimidine Metabolism.Current issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
As a traditional Chinese medicine, Centella asiatica (CA) contains diverse chemical constituents, which serve as the basis for its broad-spectrum pharmacological activities. This study aimed to investigate the therapeutic effects of CA on glycolipid metabolism disorders in ob/ob mice and conduct a systematic qualitative and quantitative analysis of the chemical composition of CA. The results demonstrated that CA extract effectively ameliorated glucose intolerance and insulin resistance, decreased blood lipid levels, and alleviated hepatic steatosis in ob/ob mice. A total of 39 chemical constituents were identified in the CA extract. To facilitate the quality evaluation of CA, we established a rapid and precise method for the simultaneous quantification of eight target compounds-asiaticoside, asiaticoside B, madecassoside, asiatic acid, madecassic acid, stachyose, kaempferol glucuronide, and quercetin-3-O-glucuronide in CA medicinal materials. Notably, this study represents the first quantitative analysis of stachyose, kaempferol glucuronide, and quercetin-3-O-glucuronide in CA, thereby complementing and expanding the existing framework for its quality control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.